Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

RXi Pharmaceuticals Corp RXII

"RXi Pharmaceuticals Corp is a clinical-stage RNAi company developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which address significant unmet medical needs."


NDAQ:RXII - Post by User

Post by mersoleil11on Jun 01, 2015 8:26am
103 Views
Post# 23783595

Did you know that stock ? take a look, could be $$$$

Did you know that stock ? take a look, could be $$$$NEWS today https://www.marketwired.com/press-release/rxi-pharmaceuticals-ceo-dr-geert-cauwenbergh-interviewed-by-the-life-sciences-report-nasdaq-rxii-2024961.htm

Extract :
"We own our self-delivering RNAi platform, and we are actively working to develop that into transformational treatments that can be used in these two areas. We also will provide licenses to other biotech companies that are interested in using our technology platform for developments in their therapeutic areas of interest."

Do your DD's about RNAI : (see video : https://www.pbs.org/wgbh/nova/body/rnai.html)


<< Previous
Bullboard Posts
Next >>